Medical Oncologist
Deciding on chemotherapy
How much does chemotherapy actually reduce your recurrence risk?
The benefit of chemotherapy depends almost entirely on your cancer. For some women it makes a large difference to the chance of recurrence; for others with small, slow-growing, hormone-sensitive cancers, the added gain is small. This page explains how benefit is measured and the questions that help you understand your own.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- How much does chemotherapy lower the chance of recurrence?
- The two ways benefit is described
- How your oncologist estimates your benefit
- The vocabulary, in plain language
- Where chemotherapy benefit tends to be larger or smaller
- What the numbers cannot tell you
- What people assume about chemotherapy benefit
- Common questions about chemotherapy benefit
The short answer
How much does chemotherapy lower the chance of recurrence?
It depends almost entirely on your cancer. For some women chemotherapy makes a large difference to the chance of the cancer coming back. For others, especially with small, slow-growing, hormone-sensitive cancers, the added benefit is very small. The number that matters is the benefit for someone with a cancer like yours, not an average.
Why there is no single figure
Chemotherapy lowers risk by a share of whatever risk you start with. A high starting risk means a large gain; a low starting risk means only a small gain, even from the same treatment.
What shapes your benefit
The size and grade of the tumour, whether lymph nodes are involved, the receptor status, your age and menopausal status, and sometimes a genomic test result. Your oncologist brings these together.
Who this explanation helps most
Women whose oncologist describes the benefit as borderline or small, and who want to understand the trade-off. If chemotherapy is clearly recommended for a high-risk cancer, the benefit is usually substantial.
This page gives general information only. Your own benefit can only be estimated by your oncologist.Reading the numbers
The two ways benefit is described
Most confusion about chemotherapy benefit comes from mixing up these two ideas.
Relative benefit
How much chemotherapy shrinks your risk as a share, such as cutting it by about a third. It sounds large, but tells you nothing on its own about how many women actually gain.
Absolute benefit
How many women out of every hundred like you avoid recurrence because of chemotherapy. This is the number that helps most with a decision.
Always ask for this one.Why they differ
Cutting a small risk by a third gains only a few women in a hundred. Cutting a large risk by the same share gains many more. The same treatment, very different value.
Survival and recurrence
Benefit can be described as fewer recurrences or as more women alive. The two figures are related but not the same, so check which one you are being given.
Useful questions
- Out of a hundred women like me, how many gain?
- Is that recurrence or survival?
- Over how many years?
How it is worked out
How your oncologist estimates your benefit
Reading the final pathology
The report from surgery gives tumour size, grade, lymph node involvement and receptor status. These are the main building blocks of any estimate.
Considering your age and health
Age, menopausal status and other health conditions affect both your starting risk and how well you might tolerate treatment.
Using prediction tools
Oncologists often use validated online tools built from large studies. These give an estimate for women with similar features, not a certainty for any one person.
Adding a genomic test where useful
For some hormone-sensitive cancers, a genomic test helps show whether chemotherapy is likely to add meaningful benefit. It is not needed for every cancer.
Discussing it with you
The estimate is then weighed against side effects and your own priorities. A good conversation covers both the benefit and what the treatment would ask of you.
Not sure whether this applies to you?
Ask an oncologistWords you will hear
The vocabulary, in plain language
- Recurrence
- The cancer coming back, either in the breast area or elsewhere in the body.
- Absolute benefit
- How many women in a hundred gain from treatment. The most useful figure for a decision.
- Relative benefit
- The share by which treatment reduces risk. Useful, but misleading on its own.
- Adjuvant chemotherapy
- Chemotherapy given after surgery to lower the chance of the cancer returning.
- Prediction tool
- An online calculator, built from large studies, that estimates benefit for women with similar features.
- Genomic test
- A test on the tumour tissue that helps show whether chemotherapy is likely to help in some hormone-sensitive cancers.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
General patterns
Where chemotherapy benefit tends to be larger or smaller
Tends to be larger
Tends to be smaller
Triple negative cancers
Small, low-grade hormone-sensitive cancers
HER2-positive cancers, with targeted therapy
A low-risk genomic test result
Several lymph nodes involved
No lymph nodes involved
Larger or high-grade tumours
Very small tumours
Younger women with higher-risk features
Older women with serious other health conditions
Being straight with you
What the numbers cannot tell you
Every estimate describes what happens across a group of women with similar cancers. It cannot tell you whether you personally would be one of the women who gain, one who would have been fine without treatment, or one whose cancer returns despite it.
Small benefits are still real choices
If the absolute benefit is small, some women choose chemotherapy because even a small gain matters to them. Others decide the side effects outweigh it. Both are reasonable when made with good information.
Beware figures from the internet
Numbers found online often describe different cancers, older treatments or relative rather than absolute benefit. Bring any figure you find to your oncologist and ask how it applies to you.
Benefit is only half the conversation
The other half is what treatment would involve: time, side effects, effects on work and family, and any long-term effects. A good decision weighs both honestly.
Estimates change as treatment improves
Prediction tools are built from studies of women treated in the past. Newer treatments, better surgery and better hormone therapy mean the real picture today may be a little different, which is another reason to treat any figure as a guide rather than a fixed answer.
What this page cannot tell you
It cannot give you your own figure. Ask your oncologist for your absolute benefit, and ask them to explain it until it makes sense to you.
Commonly believed
What people assume about chemotherapy benefit
Chemotherapy halves everyone's chance of recurrence.
The share by which it reduces risk varies, and the real gain depends on your starting risk. For a low-risk cancer, even a large relative reduction may mean only a few women in a hundred benefit.
If chemotherapy is offered, it must be essential.
Sometimes it is clearly recommended. Sometimes the benefit is borderline and your preferences genuinely matter. Asking how large the benefit is for you is a sensible question, not a refusal.
Choosing to skip chemotherapy means giving up.
When the benefit is small, deciding against it after a careful discussion is a legitimate choice. Hormone therapy and other treatments often still play a major part.
A figure from a friend's treatment applies to me.
Benefit depends on the features of each cancer. A friend's figure may describe a completely different situation, so compare only with your oncologist's estimate for your own cancer.
Questions we are asked
Common questions about chemotherapy benefit
What exactly should I ask my oncologist?
Ask how many women in a hundred with a cancer like yours avoid recurrence because of chemotherapy, whether that figure is about recurrence or survival, and over how many years. Then ask what the treatment would involve for you.
Is a small benefit worth it?
That is a personal decision. Some women want every possible gain; others feel the side effects are not worth a small one. Your oncologist can help you weigh it, and either choice can be reasonable.
Does a genomic test give me my benefit?
For some hormone-sensitive cancers, it helps show whether chemotherapy is likely to add meaningful benefit. It is one part of the picture, used alongside the other features of your cancer.
Why did my friend get chemotherapy and I did not?
Because the features of your cancers differ. Size, grade, nodes, receptors and genomic results all change the likely benefit, so two women with breast cancer can reasonably receive very different plans.
Can I see the prediction tool myself?
Some tools are publicly available, but they need accurate details from your pathology report and careful interpretation. It is best to go through the estimate together with your oncologist.
Does chemotherapy benefit change with age?
It can. Age affects both the starting risk and how well treatment is tolerated. Your oncologist considers your overall health as well as your age.
Can I get a second opinion on this decision?
Yes. When the benefit is borderline, a second opinion from another medical oncologist is a sensible and common step. Bring your pathology report and any genomic test result.
If I decline chemotherapy, can I change my mind?
There is usually a window after surgery when chemotherapy is most useful. If you are unsure, discuss the timing with your oncologist so you do not miss it while deciding.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- Cancer Research UK — Chemotherapy for breast cancer
- National Cancer Institute — Breast cancer treatment (PDQ)
- NHS — Predict Breast
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.